Figure 9From: The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluidLipid liquid chromatography mass spectrometry data, representative of four analyses from separate CSF samples. Unique lipid components differentiate P3 and S3 preparations. Total ion profiles (TIC) for A: S3, and B: P3 show the elution profile from the normal phase column for lipids: PG/PE: phosphatidylglycerol/phosphatidylethanolamine and PC: phosphatidylcholine were decreased in P3 fractions. CS: cerebroside; CM: ceramide; PI: phosphatidylinositide; PS: phosphatidylserine; PA: phosphatidic acid; SPM: sphingomyelin; PAF: platelet-activating factor; LPC: lysophosphatidylcholine. C and D: The inositol polyunsaturated fatty acid-containing lipids are greatly increased (Peak 1) in the P3 fractions. The omega 3 polyunsaturated fatty acids are increased in P3 fraction, E and F: EPA: eicosanpentanoeate, G and H, and DHA: docosahexaenoate J and K. The omega-6 polyunsaturated fatty acid is decreased, AA: arachidonic acid. The ratio of omega-3/omega-6 is significantly higher in P3 fractions (p = 0.0005).Back to article page